ClearArc Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $817K | Sell |
2,706
-1,162
| -30% | -$351K | 0.32% | 75 |
|
2019
Q3 | $929K | Buy |
3,868
+29
| +0.8% | +$6.97K | 0.27% | 91 |
|
2019
Q2 | $1.08M | Sell |
3,839
-478
| -11% | -$135K | 0.32% | 71 |
|
2019
Q1 | $1.24M | Sell |
4,317
-122
| -3% | -$35K | 0.33% | 70 |
|
2018
Q4 | $1.17M | Sell |
4,439
-2,276
| -34% | -$598K | 0.35% | 71 |
|
2018
Q3 | $1.84M | Buy |
6,715
+192
| +3% | +$52.6K | 0.24% | 98 |
|
2018
Q2 | $1.55M | Buy |
6,523
+1
| +0% | +$238 | 0.22% | 104 |
|
2018
Q1 | $1.43M | Buy |
6,522
+8
| +0.1% | +$1.76K | 0.22% | 108 |
|
2017
Q4 | $1.47M | Sell |
6,514
-243
| -4% | -$54.7K | 0.2% | 116 |
|
2017
Q3 | $1.28M | Buy |
6,757
+265
| +4% | +$50.3K | 0.19% | 119 |
|
2017
Q2 | $1.22M | Buy |
6,492
+45
| +0.7% | +$8.46K | 0.2% | 125 |
|
2017
Q1 | $1.07M | Buy |
6,447
+59
| +0.9% | +$9.76K | 0.18% | 136 |
|
2016
Q4 | $918K | Sell |
6,388
-70
| -1% | -$10.1K | 0.16% | 144 |
|
2016
Q3 | $809K | Buy |
6,458
+71
| +1% | +$8.89K | 0.15% | 155 |
|
2016
Q2 | $839K | Buy |
6,387
+14
| +0.2% | +$1.84K | 0.16% | 142 |
|
2016
Q1 | $886K | Sell |
6,373
-296
| -4% | -$41.2K | 0.19% | 135 |
|
2015
Q4 | $930K | Sell |
6,669
-3,657
| -35% | -$510K | 0.19% | 141 |
|
2015
Q3 | $1.45M | Buy |
10,326
+3,777
| +58% | +$529K | 0.3% | 86 |
|
2015
Q2 | $1.08M | Buy |
6,549
+777
| +13% | +$128K | 0.2% | 137 |
|
2015
Q1 | $891K | Buy |
5,772
+9
| +0.2% | +$1.39K | 0.18% | 155 |
|
2014
Q4 | $724K | Sell |
5,763
-9,176
| -61% | -$1.15M | 0.15% | 178 |
|
2014
Q3 | $1.79M | Buy |
14,939
+3,402
| +29% | +$407K | 0.4% | 63 |
|
2014
Q2 | $1.24M | Buy |
11,537
+1,279
| +12% | +$138K | 0.29% | 107 |
|
2014
Q1 | $1.02M | Sell |
10,258
-672
| -6% | -$66.9K | 0.25% | 117 |
|
2013
Q4 | $1.01M | Sell |
10,930
-3,258
| -23% | -$301K | 0.26% | 113 |
|
2013
Q3 | $1.19M | Sell |
14,188
-632
| -4% | -$52.8K | 0.33% | 87 |
|
2013
Q2 | $1.21M | Buy |
+14,820
| New | +$1.21M | 0.33% | 90 |
|